Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Naftifine

    • Product Name Naftifine
    • Alias Naftin
    • Einecs 262-354-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    474996

    Generic Name Naftifine
    Drug Class Antifungal
    Dosage Form Topical cream or gel
    Route Of Administration Topical
    Mechanism Of Action Inhibits squalene epoxidase
    Indications Tinea corporis, tinea cruris, tinea pedis
    Prescription Status Prescription only
    Country Of Origin United States
    Molecular Formula C21H21N
    Brand Names Naftin
    Side Effects Redness, itching, burning
    Storage Temperature Store at 20°C to 25°C (68°F to 77°F)

    As an accredited Naftifine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Naftifine is packaged in a white, labeled, sealed 50g plastic container, clearly marked with chemical name, concentration, and safety warnings.
    Shipping Naftifine should be shipped in tightly sealed containers, protected from light and moisture. Store at controlled room temperature. Follow regulations for shipping pharmaceuticals or chemicals. Ensure clear labeling and include safety data sheets (SDS). Handle with appropriate personal protective equipment, and avoid contact during transit to prevent contamination or accidental exposure.
    Storage Naftifine should be stored in a tightly closed container, protected from light and moisture. Keep it at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F). Avoid exposure to excessive heat or direct sunlight, and keep away from incompatible substances. Store in a secure location, out of reach of children and unauthorized personnel.
    Application of Naftifine

    Applications of Naftifine in Industrial Manufacturing

    As a direct producer of high-purity Naftifine, we work closely with downstream manufacturers across regulated fields. Below we outline real-world industrial applications, detailing compliance considerations, formulation practices, production stages, and the final goods into which our material is integrated.

    1. Topical Antifungal Creams and Ointments (Pharmaceutical Manufacturing)

    Pharmaceutical companies utilize Naftifine in the formulation of prescription antifungal creams and ointments for treating dermatophytic infections such as athlete's foot, jock itch, and ringworm. The precise quantity added ensures effective delivery while meeting pharmacopeial standards. Our strict production controls support seamless integration during compounding and final product filling.

    Industry compliance standards

    • USP (United States Pharmacopeia) Monographs
    • European Pharmacopoeia (Ph. Eur.)
    • GMP (Good Manufacturing Practices) per ICH Q7 and WHO guidelines
    • 21 CFR Part 210/211 (FDA regulations for pharmaceuticals)

    Typical usage ratio

    • 1.0% w/w as the standard API content per final formulation
    • Formulators may adjust within 0.75–1.0% to meet regulatory requirements and clinical study data

    Downstream process integration

    • Dispersion in the cream or ointment base during compounding
    • Homogenization with excipients prior to degassing and tube/jar filling
    • QC sampling for API uniformity following blending

    Final product types

    • Prescription antifungal creams (dermatological applications)
    • Non-prescription over-the-counter topical ointments
    • Combination therapy bases with corticosteroids (where permitted by local regulatory authorities)

    2. Antifungal Gel Formulations for Medical Use

    Medical device and pharmaceutical producers add Naftifine to hydrogel and alcohol-based gel formulations intended for topical clinical application under professional supervision. These products require both uniform dispersion and stability throughout shelf life, leading to stringent controls over addition point and quantity.

    Industry compliance standards

    • EU Directive 2001/83/EC on medicinal products
    • ISO 13485 for medical device-related gels containing APIs
    • MHRA (UK Medicines and Healthcare Products Regulatory Agency) labeling and QA requirements
    • Japanese Pharmacopoeia, where distributed in Asia Pacific

    Typical usage ratio

    • 0.5–1.0% w/w, typically set at 1.0% for standard antifungal gels
    • Adjustment within 0.5–1.0% for pediatric or geriatric formulations per clinical protocol

    Downstream process integration

    • Inclusion during hydrogel polymerization or gel base blending
    • API addition under controlled temperature and mixing conditions to prevent degradation
    • Inline filtration prior to automatic tube or sachet dosing

    Final product types

    • Topical antifungal gels for hospital and outpatient use
    • Pre-filled single-use gel sachets
    • Hydrogel dressings containing antifungal actives

    3. Antifungal Solution Formulations for Skin Application

    Dermaceutical and pharmaceutical laboratories employ Naftifine in alcohol or glycol-based solution formulations where rapid dermal absorption is prioritized. These products support the direct delivery of active substance for patients with scaling or hyperkeratosis, requiring clear guidance on both permitted concentrations and approved excipients.

    Industry compliance standards

    • EMA (European Medicines Agency) topical product guidelines
    • FDA Topical Drug Product Quality Guidance
    • GMP compliance (PIC/S guidelines) throughout production and filling
    • Product registration with local drug authorities (ANVISA, CFDA, etc.)

    Typical usage ratio

    • 1.0% w/v is standard in most topical solutions
    • Lower concentrations (0.5–0.8%) used in pediatric or sensitive-skin variants by manufacturer discretion and regulatory approval

    Downstream process integration

    • Direct dissolution into pre-filtered solvent base (ethanol, propylene glycol, or blends)
    • API solubilization with controlled agitation to ensure clarity
    • Microbial QA sampling before bottling

    Final product types

    • Clear antifungal skin solutions (dropper bottles)
    • Pump spray antifungal solutions
    • Medicated wipes pre-soaked in Naftifine solution

    4. Antifungal Powder Preparations in External Use Pharmaceuticals

    Producers formulate powders containing Naftifine for dusting onto skin and within footwear, primarily to address tinea infections in humid environments. Formulation must account for flow properties, ingredient compatibility, and precise active distribution, complying with requirements for particle size and microbial purity.

    Industry compliance standards

    • Ph. Eur. and USP standards for medicated powders
    • WHO GMP for external-use pharmaceuticals
    • REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) safety data requirements for European markets
    • Internal QC testing per ISO/IEC 17025

    Typical usage ratio

    • 1.0% w/w of API in the powder blend is common practice
    • Usage may range from 0.8% to 1.0% depending on product strength regulations in different markets

    Downstream process integration

    • Uniform blending with talcum or absorbent starch bases in high-shear mixers
    • API screening with active ingredient control testing after mixing
    • Smaller batch sampling before final container dosing

    Final product types

    • Medicated antifungal powders for direct skin or foot application
    • Antifungal dusting powders for industrial and sports-use footwear
    • Pediatric antifungal powder sachets, produced under closely controlled conditions

    5. Antifungal Emulsion Preparations for Scalp Treatments

    Manufacturers develop emulsified products incorporating Naftifine for use in clinical scalp therapies against fungal infections that resist standard treatments. These complex oil-in-water systems require stabilized dispersion and meet hair/scalp compatibility standards, ensuring uniformity across each batch and meeting both cosmetic and medical regulatory frameworks.

    Industry compliance standards

    • COSMOS/Ecocert cosmetic formulation guidance (for combined medical/cosmetic lotions)
    • Ph. Eur. specifications for topical emulsions with API inclusion
    • National authorities’ approval, such as FDA’s Cosmetic/Drug regulations for scalp treatments
    • GMP compliance in batch production, filling, and final product testing

    Typical usage ratio

    • 1.0% w/w in finished emulsion for adult scalp products
    • For special hair compatibility, can decrease to 0.5% under pediatric or sensitive-use protocols

    Downstream process integration

    • Emulsification alongside vegetable or synthetic oils, with API introduced at the aqueous phase stage
    • High-shear mixing and particle size control through inline homogenizers
    • Finished emulsion passed through microbial and stability QC before filling

    Final product types

    • Scalp lotions and creams for fungal infections
    • Medicated leave-in scalp emulsions
    • Prescription antifungal hair serums for specific clinical indications
    Free Quote

    Competitive Naftifine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Naftifine: An In-Depth Look from the Manufacturer’s Perspective

    What Sets Naftifine Apart in the World of Active Pharmaceutical Ingredients

    Naftifine stands out as a topical ally for managing fungal skin infections. In our production facilities, we deal directly with Naftifine hydrochloride, ensuring that the final output meets purity standards needed by formulators. This synthetic allylamine antifungal has been sharpened over decades to consistently address dermatophyte infections, helping both patients and the companies producing topical creams or gels.

    Touching base on experience from our production floor, we notice trends quickly. Demand for topical antifungals keeps growing, and every kilogram of Naftifine we synthesize undergoes strict quality checks. This comes from a blend of advanced processing equipment, careful raw material selection, and decades of expertise. Each batch meets requirements for identification, purity, and particle size. Developers looking for reliable actives do not overlook these factors; the consequences show up in clinical performance.

    Understanding Why Performance Starts with Raw Material Quality

    Every synthesis of Naftifine starts with a focus on feedstock. We insist on thoroughly screened building blocks before heading to alkylation, hydrogenation, and subsequent steps in the route. If impurities slip through, the safety and outcome of the final cream can falter. Feedback from downstream partners often circles back to this point: product stability and shelf life owe much to supplier discipline. There’s little room for shortcuts if you want compliant Naftifine.

    Through years of production, we find unchecked moisture and uncontrolled pH sway quality more than some realize. Makers lose time addressing problems that started upstream. Strict controls at every step, from weighing to filtration and drying, help shield the final molecule from variability. Teams in formulation notice this difference; poor quality Naftifine clumps, and off-color material triggers costly rework or outright batch rejection.

    Production Consistency: Hard Lessons Learned

    Our production line sees many antifungal molecules. Naftifine draws particular attention because its hydrochloride form is more sensitive to moisture than some related actives. Fail to control storage humidity, and you will see caking or even hydrolysis. Over the years, we optimize our drying and packaging methods by running stability studies at varying temperatures and humidity points. We record those findings, hone parameters, and invest in packaging that keeps the active dry from our site to the customer’s compounding room.

    Our model Naftifine runs from 99.0% to 101.0% purity, consistent batch to batch, according to HPLC. Analysis for related substances stays tight, preventing bioactive side products from ever being a concern. Particle size is monitored with laser diffraction. Cream and gel manufacturers often ask for micronized lots, so we run jet milling when called for. We communicate this openly because formulation success—whether for a hospital product or an over-the-counter treatment—depends on blending and absorption that only come with proper control over physical parameters.

    Specifications and Practical Manufacturing Experience

    Typical specifications include a white to off-white crystalline powder appearance, with solubility in alcohols and limited aqueous solubility. In day-to-day manufacture, odors or slight off-whites are early warning signals for over-dried, overheated material. Our in-process control team tracks these deviations stringently. Feedback loops help us tweak every parameter, from particle sieving mesh size to the finish time for rotary evaporation stages.

    Formulators rely on Naftifine’s proven compatibility with excipients commonly found in topical bases. Each year, we help troubleshoot challenges: uneven suspension, crystallization in finished creams, erratic color in gels under certain pH. Our team often advises on pH adjustment to keep Naftifine reliably dissolved—usually between pH 4 and 6, where the hydrochloride salt sits stably in most cream vehicles.

    Unlike terbinafine, another widely used allylamine, Naftifine suits topical application because it achieves strong local concentrations in the stratum corneum without significant systemic exposure. Our repeated stability studies show that Naftifine resists degradation under normal conditions, provided packaging integrity is maintained. Packaging upgrades in the last decade—a move from simple double polyethylene to multi-layered foil-lined drums—originate from customer feedback and real-world transport studies.

    Key Differences: Naftifine Versus Other Antifungals

    From the manufacturer’s point of view, we constantly field questions about “what makes Naftifine different?” The primary distinction lies in its specific spectrum and mode of action. Working as a squalene epoxidase inhibitor, Naftifine starves dermatophyte fungi of a crucial ergosterol precursor, resulting in potent fungicidal activity. Compared to imidazoles, which bind to a different part of the sterol pathway, Naftifine reaches activity targets more quickly in common tinea infections.

    In our labs, we also synthesize the likes of clotrimazole, miconazole, and terbinafine. Imidazoles tend to require longer exposure periods and occasionally trigger more irritation in some base formulations. Terbinafine, though structurally related, is more often reserved for oral or systemic infection treatment. Our Naftifine, with its topical focus, draws interest precisely because it achieves strong local concentrations without entering the systemic circulation to any meaningful degree, letting finished products secure good safety profiles. Hospital and consumer brands both notice: rapid symptom relief matters for patient compliance and reputation alike.

    The Processes Required for Pharmaceutical-Grade Naftifine

    Producing Naftifine hydrochloride for pharmaceutical purposes involves more than basic chemical knowledge. We maintain process validation documentation and batch histories for every lot shipped. Routine samples are pulled for full spectrum analysis: HPLC, titrimetric assays, IR, and even NMR as needed. Discrepancies, even minor, start investigative action. Our in-house team has learned, factory shutdowns for “corrective action” cost more than preventive calibration, so we schedule regular upkeep and training.

    Some would say documentation creates more work. Yet, our experience says otherwise: every misplaced decimal or incomplete log can ripple forward to bigger headaches. Tracking retention samples over years gives our partners confidence in long-term stability. Raw data builds trust; we never shortcut quality operations, knowing that every downstream product—from a simple tube of cream to a multi-million unit supply contract—demands consistency.

    End-User Applications and Manufacturing Support

    End users reach out for Naftifine in a host of applications. Though most often found in 1% cream or gel, some partners request custom concentrations, especially for combination products or pediatric formulations. In our facilities, we prepare for this by keeping dedicated mixing and micronization lines available, with tailored clean-down protocols to prevent cross-contamination. Developers often need technical data: stability in complex vehicles, solubility in glycols or water-ethanol blends, compatibility with preservatives or fragrance additives. Our R&D unit invests time in these studies because real-world results show up fast—unstable formulas stop moving off shelves within months.

    We also take part in regulatory documentation. From Europe to North America, questions arise over residual solvents, elemental impurities, and microbiological safety. Each region demands its paperwork be in order, often tailored to national standards. Our regulatory affairs staff assist with this step by step, using years of experience handling DMFs and CEP submissions. Troubleshooting occurs alongside customers, not just behind closed doors, so misunderstandings never derail projects on a technicality.

    Learning from Long-Term Experience: Continuous Improvement in Naftifine Production

    Continuous improvement isn’t a slogan to us; it’s the reason our Naftifine has served customers across continents for more than 20 years. From the earliest days, we grappled with solvent selection and distillation columns that never seemed to pull fractions cleanly enough. Today’s reactors and filtration methods bring higher yields, less waste, and smoother operation. Yet the real lesson has been this: listening to partners brings the best innovations.

    Feedback on solubility, ease of blending, or trace odor issues prompt targeted investments. Our pilot programs developed an advanced washing technique that pinpoints hard-to-remove traces of byproducts. Teamwork between analytical chemists and plant operators has led to protocols where internal audits happen before every major lot is released to packaging—a practice borrowed from our most demanding clients. Even small improvements—changing sieve mesh size, adjusting filter-drying sequences, monitoring particle breakage—create results. Each year, performance data and client feedback drive material tweaks.

    Sustainability and Responsible Manufacturing

    Regulatory bodies and customers alike increasingly demand evidence of responsible production. Our operations match up. We invested in closed-loop solvent recovery, which cuts emissions and waste handling fees. For each kilo of Naftifine, we recover upwards of 96% of spent organic solvents by distillation. Over the past five years, water usage fell by 30% per batch, thanks to a shift to dry cleaning procedures between lots and water-saving rinse tanks.

    Our site manages active waste by both concentration and treatment, disposal records are logged with environmental authorities, and we certify complete traceability of key chemicals. These steps build trust—not only with regulators, but with savvy customers whose contracts demand evidence of compliance down to the packaging tape. As a manufacturer, we know these requirements grow more complex each year. Instead of fighting the trend, we design with future regulations in mind, so our Naftifine supply stays uninterrupted even as standards tighten.

    Why Direct Manufacturer Sourcing Matters for Naftifine

    Direct relationships between API manufacturers and product developers shorten response times and reduce price markups. Beyond the cost, real-time communication solves problems early. If a customer’s development team flags an issue—like a persistent suspension in their gel base—our technical team can pull up full process data, double-check solubility specs, and arrange overnight courier for a new test sample. Intermediaries simply can’t replicate this kind of support.

    Every so often, economic conditions shake up the API market. Price volatility or sudden raw material shortages test supply chain resilience. Over years of turbulence, from global shipping delays to shifting regulatory expectations, we find direct connections keep projects moving forward. Our batch scheduling, logistics, and technical support remain responsive because we deal directly with the teams that formulate finished medicines. We’re not a faceless widget vendor; we see the end result in every tube, bottle, or batch of cream shipped out.

    What Pharmacists, Developers, and Producers Gain from Quality Naftifine

    Pharmacists and formulation developers share real-life stories about unstable APIs causing headaches: unexpected crystallization ruining an entire tank, color shifts prompting complaints, or viscosity changes wrecking a cream’s feel. Our team handles queries from the field, especially about compatibility with common gelling agents or preservatives. The advice we give comes from hands-on troubleshooting in our labs. From adjusting lots to meet critical micelle concentration needs to running flash tests for premature oxidation, we face these issues directly.

    We stay close to our customers, troubleshooting, recommending best practices, and following up on every question about process scale-up or new dosage forms. Over the years, pharmacists and production chemists come to us for critical details: How best to blend Naftifine into a new hydrogel? What grade of purity prevents unwanted reactions in a combination product? We remember that no product succeeds without safe, consistent active ingredients; each inquiry shapes the next run through our reactors.

    Ongoing Research and Proposed Solutions to Industry Challenges

    The pharmaceutical industry changes quickly—a new delivery system, a shift in regulatory requirements, or a novel skin application can reframe earlier assumptions. Our R&D team keeps up by supporting pilot programs. Recently, we explored micronized grades of Naftifine for sprays and foams. The questions asked by device makers—particle suspension quality, rate of dissolution, compatibility with novel plastics—push our team to try and anticipate the next set of technical hurdles before they hit client projects.

    We also partner with academic institutes on new antifungal combination therapies. These collaborations yield studies on stability, absorption, and emerging fungal resistance, arming us and our customers with the data regulators demand. It’s not trivial work: each new data point might require revalidating a process, modifying a filter column, or sourcing a new analytical standard.

    Problems pop up—unsuitable excipient pairing, poor shelf life under certain packaging, or new regulations on impurities. We offer solutions: send material early for compatibility testing, run parallel stability studies, and share process documentation. Our experience shows that transparent collaboration solves regulatory and technical issues far faster than isolated troubleshooting can. This way, both new and established product launches run more smoothly and keep their edge as market expectations rise.

    Building for the Future with Reliable Naftifine Production

    A reputation doesn’t build itself. We invest daily in training, facility upgrades, and rigorous compliance because the end users—patients, pharmacists, and physicians—expect safe, effective treatments. Adapting production parameters, keeping up with shifting GMP guidelines, and listening to customer feedback keeps our product line current and competitive. Year by year, improvements in Naftifine purity, stability, and packaging trace back to conversations with partners and colleagues, all centered around real-world results.

    As a manufacturer rooted in chemical production and pharmaceutical partnerships, we view Naftifine as more than just another item on our catalog. The difference lies in attentive sourcing, hands-on process control, and continuous communication from plant floor to formulation bench. Our goal remains clear: supply a reliable, proven antifungal active that helps partners create standout products and supports patients returning to comfort and health.